Alternatives to Arzeda

AI-powered drug discovery and development platform for biologics.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Leveraging the adaptive immune system to diagnose and treat disease.

AI-guided drug discovery platform for tissue-targeted medicines.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Vexxel is developing a novel platform for cell-free protein synthesis and engineering.

AI-powered platform for personalized cell therapy development and manufacturing.

Advance every cancer decision.

AI-driven drug discovery platform for rapid development of novel therapeutics.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI-powered platform for designing novel molecular structures for new medicines.

AI-powered platform for antibody discovery and development to create new medicines.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.